SENZUMODERN REBIRTHMy account BPC-157
Also known as Body Protection Compound-157 · gastric pentadecapeptide BPC-157
There is no adequate randomized human evidence establishing recovery, musculoskeletal, or gastrointestinal benefit. Popularity and preclinical signals should not be mistaken for proven clinical outcomes.
- Evidence maturity
- Early signal
- Regulatory status
- Not FDA approved
- Recorded outcomes
- 3
- Indexed sources
- 2
This profile does not recommend a compound, dose, supplier, or treatment plan. Discuss personal decisions with a qualified clinician who knows your history.
Summary
An unapproved experimental peptide supported mainly by cell and animal injury models.
What is BPC-157 being studied for?
Musculoskeletal and gastrointestinal research
How is it thought to work?
Human mechanism is unestablished. Proposed nitric-oxide, angiogenesis, vascular, and tissue-repair pathways come largely from preclinical work.
Recorded outcomes
3 graded outcomes and 2 sources for BPC-157.
The graded outcome table, how each grade was decided, the regulatory detail, and every source with its link and identifier open with a free account. No payment details required.
Update history
- Editorial review of the profile and its sources.
- Record last updated in the Senzu database.
- Profile first published.